Abstract
We present a case of a 32-year-old woman with hyperparathyroidism, treated with ultrasound-guided percutaneous radiofrequency ablation (RFA). RFA, assisted by saline injection inferomedial to the parathyroid, is a safe technique that prevents burn injury to the nerve. The saline injection technique shifted the parathyroid gland laterally, so that the distance between the nerve and the parathyroid gland was sufficient to prevent burn injury. The completeness of tissue ablation was evaluated based on Doppler ultrasound imaging and serum intact parathyroid hormone (iPTH) level immediately after RFA. There were no complications associated with RFA. Serum iPTH levels normalized during follow-up for 20 months. It was possible to perform RFA for primary parathyroid adenoma safely using a saline injection technique.
Similar content being viewed by others
References
Mihai R, Barczynski M, Iacobone M, et al. Surgical strategy for sporadic primary hyperparathyroidism an evidence-based approach to surgical strategy, patient selection, surgical access, and reoperations. Langenbecks Arch Surg. 2009;394(5):785–98.
Gracie D, Hussain SS. Use of minimally invasive parathyroidectomy techniques in sporadic primary hyperparathyroidism: systematic review. J Laryngol Otol. 2012;126(3):221–7.
Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radio-frequency energy. Radiology. 2000;217(3):633–46.
Shin JH, Baek JH, Ha EJ, et al. Radiofrequency ablation of thyroid nodules: basic principles and clinical application. Int J Endocrinol. 2012;2012:919650. doi:10.1155/2012/919650.
Hänsler J, Harsch IA, Strobel D, et al. Treatment of a solitary adenoma of the parathyroid gland with ultrasound-guided percutaneous Radio-Frequency-Tissue-Ablation (RFTA). Ultraschall Med. 2002;23(3):202–6.
Carrafiello G, Laganà D, Mangini M, et al. Treatment of secondary hyperparathyroidism with ultrasonographically guided percutaneous radiofrequency thermoablation. Surg Laparosc Endosc Percutan Tech. 2006;16(2):112–6.
Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009;34(3):371–80.
Kapoor BS, Hunter DW. Injection of subphrenic saline during radiofrequency ablation to minimize diaphragmatic injury. Cardiovasc Intervent Radiol. 2003;26(3):302–4.
Goldberg SN, Ahmed M, Gazelle GS, et al. Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology. 2001;219(1):157–65.
Cha J, Choi D, Lee MW, et al. Radiofrequency ablation zones in ex vivo bovine and in vivo porcine livers: comparison of the use of internally cooled electrodes and internally cooled wet electrodes. Cardiovasc Intervent Radiol. 2009;32(6):1235–40.
Randolph GW. Surgery of the thyroid and parathyroid glands. 2nd ed. Philadelphia: Saunders; 2013. p. 553–4.
Solbiati L, Osti V, Cova L, et al. Ultrasound of thyroid, parathyroid glands and neck lymph nodes. Eur Radiol. 2001;11(12):2411–24.
Randolph GW. Surgery of the thyroid and parathyroid glands. 2nd ed. Philadelphia: Saunders; 2013. p. 310.
Lew JI, Irvin GL 3rd. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery. 2009;146(6):1021–7.
Kakuta T, Suzuki Y, Tadaki F, et al. Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism. Biomed Pharmacother. 2002;56:41–7.
Cercueil JP, Jacob D, Verges B, et al. Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results. Eur Radiol. 1998;8(9):1565–9.
Cappelli C, Pelizzari G, Pirola I, et al. Modified percutaneous ethanol injection of parathyroid adenoma in primary hyperparathyroidism. QJM. 2008;101(8):657–62.
Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9.
Mandal PK, Ray S, Basu N. Parathyroid carcinoma uncovering the enigma: case report and review of literature. J Cytol. 2011;28(4):223–5.
Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13(1):11–23.
Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86(2):485–93.
Bae JH, Choi HJ, Lee Y, et al. Preoperative predictive factors for parathyroid carcinoma in patients with primary hyperparathyroidism. J Korean Med Sci. 2012;27(8):890–5.
Cavalier E, Daly AF, Betea D, et al. The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma. J Clin Endocrinol Metab. 2010;95(8):3745–9.
Caron P, Maiza JC, Renaud C, et al. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2009;70(4):533–8.
Wieneke JA, Smith A. Parathyroid adenoma. Head Neck Pathol. 2008;2(4):305–8.
Conflict of interest
There are no financial or other relations that could lead to a conflict of interest.
Ethical standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from the patient for being included in the study.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kim, B.S., Eom, T.I., Kang, K.H. et al. Radiofrequency ablation of parathyroid adenoma in primary hyperparathyroidism. J Med Ultrasonics 41, 239–243 (2014). https://doi.org/10.1007/s10396-013-0501-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10396-013-0501-0